Thurston Springer Miller Herd & Titak Inc. Acquires 9,682 Shares of Colgate-Palmolive (NYSE:CL)

Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 69.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,676 shares of the company's stock after acquiring an additional 9,682 shares during the quarter. Thurston Springer Miller Herd & Titak Inc.'s holdings in Colgate-Palmolive were worth $2,152,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of CL. FMR LLC raised its position in shares of Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock worth $700,642,000 after purchasing an additional 2,674,807 shares during the period. Barclays PLC grew its stake in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares during the last quarter. State Street Corp increased its position in Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the period. Nordea Investment Management AB lifted its stake in Colgate-Palmolive by 32.5% in the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company's stock valued at $462,121,000 after buying an additional 1,247,731 shares during the last quarter. Finally, AQR Capital Management LLC boosted its holdings in shares of Colgate-Palmolive by 58.6% during the second quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company's stock valued at $234,540,000 after acquiring an additional 892,706 shares during the period. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 0.3 %

CL traded up $0.23 during mid-day trading on Wednesday, reaching $87.90. The stock had a trading volume of 5,125,300 shares, compared to its average volume of 5,203,934. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 52 week low of $79.69 and a 52 week high of $109.30. The stock has a market capitalization of $71.82 billion, a P/E ratio of 25.19, a P/E/G ratio of 3.31 and a beta of 0.44. The firm's fifty day simple moving average is $92.36 and its two-hundred day simple moving average is $97.92.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.37% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on CL shares. Stifel Nicolaus cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $105.00 to $101.00 in a report on Monday, October 28th. StockNews.com cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th. TD Cowen cut their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. Finally, Piper Sandler lowered their target price on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $103.63.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.